Immunovia AB
IMMNOV
Rank in Stocks
#34468
Immunovia AB (publ), a diagnostic company, develops blood diagnostic for... Immunovia AB (publ), a diagnostic company, develops blood diagnostic for detecting pancreatic cancer in Sweden. It also focuses on the development and commercialization of blood-based testing to detect proteins and antibodies that indicate pancreatic cancer in an individual. Immunovia AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden.
Share Price
$0.00767392
Market Cap
$5.16M
Change (1 day)
-17.12%
Change (1 year)
-85.26%
Country
SE
Trade Immunovia AB (IMMNOV)
Category
Healthcare
Stock price history for Immunovia AB (IMMNOV)
Highest end of day price: $0.01 on 2026-10-01
Lowest end of day price: $6.16 on 2019-06-01
Lowest end of day price: $6.16 on 2019-06-01
Stock price history of Immunovia AB from 2019 to 2026
Annual Stock Price Performance
| Year | Performance |
|---|---|
| 2026 (TTM) | -49.87% |
| 2025 | -2.79% |
| 2024 | -50.93% |
| 2023 | -90.35% |
| 2022 | -60.80% |
| 2021 | -55.60% |
| 2020 | 0.32% |
| 2019 | 0.00% |
Stock price for similar companies or competitors
| Company | Stock price | Change 1y% | Country |
|---|---|---|---|
| $694.53 | 24.47% |
US
|
|
| $234.00 | 5.99% |
US
|
|
| $416.01 | 122.61% |
US
|
|
| $22.06 | 54.01% |
CN
|
|
| $177.93 | 22.13% |
US
|
